Responses
Oral Presentations
WEDNESDAY, 12 JUNE 2019
RA therapy –JAK inhibitors and beyond
OP0025 FENEBRUTINIB COMPARED TO PLACEBO AND ADALIMUMAB IN PATIENTS WITH INADEQUATE RESPONSE TO EITHER METHOTREXATE THERAPY OR PRIOR TNF THERAPY: PHASE 2 STUDY
Compose a Response to This Article
Other responses
No responses have been published for this article.